These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11462203)

  • 1. Tuberculosis drug serum levels.
    Peloquin CA
    Clin Infect Dis; 2001 Aug; 33(4):584-5. PubMed ID: 11462203
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyrazinamide serum levels in childhood tuberculosis.
    Thee S; Detjen A; Wahn U; Magdorf K
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1099-101. PubMed ID: 18713511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers and surrogate end points in clinical trials of tuberculosis treatment.
    Davies GR; Phillips PP; Nunn AJ
    J Infect Dis; 2007 Aug; 196(4):648-9; author reply 649-50. PubMed ID: 17624855
    [No Abstract]   [Full Text] [Related]  

  • 4. BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005.
    Pozniak AL; Miller RF; Lipman MC; Freedman AR; Ormerod LP; Johnson MA; Collins S; Lucas SB;
    HIV Med; 2005 Jul; 6 Suppl 2():62-83. PubMed ID: 16011537
    [No Abstract]   [Full Text] [Related]  

  • 5. AIDS and TB drug absorption.
    Peloquin CA; Berning SE; Huitt GA; Iseman MD
    Int J Tuberc Lung Dis; 1999 Dec; 3(12):1143-4. PubMed ID: 10599022
    [No Abstract]   [Full Text] [Related]  

  • 6. Two excellent management tools for national tuberculosis programmes.
    Barker RD; Millard FJ
    Int J Tuberc Lung Dis; 1999 May; 3(5):454-5. PubMed ID: 10331737
    [No Abstract]   [Full Text] [Related]  

  • 7. [The specific features of bacterial isolation and drug resistance of Mycobacteria in extrapulmonary tuberculosis].
    Vishnevskiĭ BI; Manicheva OA; Vishnevskaia EB; Mel'nikova NN; Otten TF
    Probl Tuberk Bolezn Legk; 2006; (11):18-21. PubMed ID: 17195585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum concentrations of anti-tuberculosis agents: do they matter?
    Donald PR
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):937. PubMed ID: 17705967
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy effectiveness of tuberculosis patients in intensive phase (2-3 months)].
    Khomenko AG; Punga VV; Grishina TA; Stoiunin MB; Danilova ID; Rybka LN
    Probl Tuberk; 1996; (5):13-6. PubMed ID: 8984478
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy in tuberculosis].
    Somoskövi A; Lantos A
    Orv Hetil; 2004 Apr; 145(16):871-3. PubMed ID: 15156693
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug resistance in tuberculosis.
    Ebrahim GJ
    J Trop Pediatr; 2007 Jun; 53(3):147-9. PubMed ID: 17526511
    [No Abstract]   [Full Text] [Related]  

  • 12. [Principles underlying the use of antituberculosis medication in children].
    Ollivier A; Besson-Leaud M
    Ann Pediatr (Paris); 1979 Mar; 26(3):141-7. PubMed ID: 16108274
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethambutol in paediatric tuberculosis: aspects of ethambutol serum concentration, efficacy and toxicity in children.
    Thee S; Detjen A; Quarcoo D; Wahn U; Magdorf K
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):965-71. PubMed ID: 17705973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of plasma levels of isoniazid for dose adjustment in the hemodialysis patients.
    El Kabbaj D; Aatif M; Moussa LA; Khassouani CE; Oualim Z
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):666-7. PubMed ID: 19587514
    [No Abstract]   [Full Text] [Related]  

  • 15. Efforts of the WHO/IUATLD to solve the problem of poor bioavailability of rifampicin from FDC anti-tuberculosis products: is a change required in the direction of the approach in view of recent findings?
    Singh S
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):880-2. PubMed ID: 11573905
    [No Abstract]   [Full Text] [Related]  

  • 16. Azole antifungals as novel chemotherapeutic agents against murine tuberculosis.
    Ahmad Z; Sharma S; Khuller GK
    FEMS Microbiol Lett; 2006 Aug; 261(2):181-6. PubMed ID: 16907718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of latent tuberculosis infection: back to the beginning.
    Blumberg HM
    Clin Infect Dis; 2004 Dec; 39(12):1772-5. PubMed ID: 15578398
    [No Abstract]   [Full Text] [Related]  

  • 18. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
    Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-tuberculosis treatment and infliximab.
    Wallis RS
    Respir Med; 2005 Dec; 99(12):1620-2. PubMed ID: 16039841
    [No Abstract]   [Full Text] [Related]  

  • 20. Shortening the treatment of tuberculosis.
    Mitchison DA
    Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.